155 related articles for article (PubMed ID: 10505957)
1. Disposition and tolerance of suxibuzone in horses.
Jaraiz MV; Rodriguez C; San Andres MD; Gonzalez F; San Andres MI
Equine Vet J; 1999 Sep; 31(5):411-6. PubMed ID: 10505957
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and bioequivalence of two suxibuzone oral dosage forms in horses.
Jaraiz V; Rodriguez C; San Andres MD; Gonzalez F; San Andres MI
J Vet Pharmacol Ther; 1999 Aug; 22(4):247-54. PubMed ID: 10499236
[TBL] [Abstract][Full Text] [Related]
3. The disposition of suxibuzone in the horse.
Delbeke FT; Vynckier L; Debackere M
J Vet Pharmacol Ther; 1993 Sep; 16(3):283-90. PubMed ID: 8230399
[TBL] [Abstract][Full Text] [Related]
4. The intramuscular bioavailability of a phenylbutazone preparation in the horse.
Landuyt J; Delbeke FT; Debackere M
J Vet Pharmacol Ther; 1993 Dec; 16(4):494-500. PubMed ID: 8126767
[TBL] [Abstract][Full Text] [Related]
5. The effect of inflammation on the disposition of phenylbutazone in thoroughbred horses.
Mills PC; Ng JC; Auer DE
J Vet Pharmacol Ther; 1996 Dec; 19(6):475-81. PubMed ID: 8971677
[TBL] [Abstract][Full Text] [Related]
6. Comparative pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in clinically normal horses and donkeys.
Mealey KL; Matthews NS; Peck KE; Ray AC; Taylor TS
Am J Vet Res; 1997 Jan; 58(1):53-5. PubMed ID: 8989496
[TBL] [Abstract][Full Text] [Related]
7. Phenylbutazone in racing greyhounds: plasma and urinary residues 24 and 48 hours after a single intravenous administration.
Mills PC; Ng JC; Skelton KV; Seawright AA; Auer DE
Aust Vet J; 1995 Aug; 72(8):304-8. PubMed ID: 8579562
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamics and pharmacokinetics of phenylbutazone in calves.
Arifah AK; Lees P
J Vet Pharmacol Ther; 2002 Aug; 25(4):299-309. PubMed ID: 12213119
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic studies of flunixin meglumine and phenylbutazone in plasma, exudate and transudate in sheep.
Cheng Z; McKeller Q; Nolan A
J Vet Pharmacol Ther; 1998 Aug; 21(4):315-21. PubMed ID: 9731955
[TBL] [Abstract][Full Text] [Related]
10. Solid-phase extraction for the high-performance liquid chromatographic determination of indomethacin, suxibuzone, phenylbutazone and oxyphenbutazone in plasma, avoiding degradation of compounds.
Caturla MC; Cusido E
J Chromatogr; 1992 Oct; 581(1):101-7. PubMed ID: 1429991
[TBL] [Abstract][Full Text] [Related]
11. Metabolism, excretion, pharmacokinetics and tissue residues of phenylbutazone in the horse.
Lees P; Taylor JB; Maitho TE; Millar JD; Higgins AJ
Cornell Vet; 1987 Apr; 77(2):192-211. PubMed ID: 3568689
[TBL] [Abstract][Full Text] [Related]
12. Multicentre, controlled, randomised and blinded field study comparing efficacy of suxibuzone and phenylbutazone in lame horses.
Sabaté D; Homedes J; Salichs M; Sust M; Monreal L
Equine Vet J; 2009 Sep; 41(7):700-5. PubMed ID: 19927590
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and pharmacodynamic studies on phenylbutazone and oxyphenbutazone in goats.
Cheng Z; Welsh E; Nolan A; McKellar QA
Vet Rec; 1997 Jan; 140(2):40-3. PubMed ID: 9123796
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in miniature donkeys.
Matthews NS; Peck KE; Taylor TS; Mealey KL
Am J Vet Res; 2001 May; 62(5):673-5. PubMed ID: 11341383
[TBL] [Abstract][Full Text] [Related]
15. Effects of top-dress formulations of suxibuzone and phenylbutazone on development of gastric ulcers in horses.
Andrews FM; Reinemeyer CR; Longhofer SL
Vet Ther; 2009; 10(3):113-20. PubMed ID: 20037965
[TBL] [Abstract][Full Text] [Related]
16. Plasma and serum concentrations of phenylbutazone and oxyphenbutazone in racing Thoroughbreds 24 hours after treatment with various dosage regimens.
Soma LR; Sams R; Duer W; Tobin T; Woodward C; McDonald J
Am J Vet Res; 1985 Apr; 46(4):932-8. PubMed ID: 4014842
[TBL] [Abstract][Full Text] [Related]
17. Lower gastric ulcerogenic effect of suxibuzone compared to phenylbutazone when administered orally to horses.
Monreal L; Sabaté D; Segura D; Mayós I; Homedes J
Res Vet Sci; 2004 Apr; 76(2):145-9. PubMed ID: 14672858
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of intravenous and intragastric cimetidine in horses. I. Effects of intravenous cimetidine on pharmacokinetics of intravenous phenylbutazone.
Sams RA; Gerken DF; Dyke TM; Reed SM; Ashcraft SM
J Vet Pharmacol Ther; 1997 Oct; 20(5):355-61. PubMed ID: 9350255
[TBL] [Abstract][Full Text] [Related]
19. Phenylbutazone pharmacokinetics and bioavailability in the dromedary camel (Camelus dromedarius).
Kadir A; Ali BH; al Hadrami G; Bashir AK; Landoni MF; Lees P
J Vet Pharmacol Ther; 1997 Feb; 20(1):54-60. PubMed ID: 9049950
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of phenylbutazone in camels.
Wasfi IA; Abdel Hadi AH; Zorob O; Osman M al-G ; Boni NS
Am J Vet Res; 1997 Jun; 58(6):636-40. PubMed ID: 9185972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
